Supplementary Figure S4 from Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer
Key Points
Key points are not available for this paper at this time.
Abstract
Time on treatment among patients with long-term response (LTR).
Demander à l'IA
Like
Bookmark
Share
Demander à l'IA
Like
Bookmark
Share
Supplementary Figure S4 from Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer | Synapse
Cite This Study
Thummalapalli et al. (Mon,) studied this question.